MetaCap

Helus Pharma Insider Trades

NASDAQ: HELPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.11-0.67 (-9.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
9 · $9.67M
Sales
0 · $0
Shares bought / sold
788.00K / 0
Net activity
Net buying $9.7 million

Helus Pharma insider activity

Over the last 12 months, Helus Pharma insiders reported 11 transactions on SEC Form 4: 9 open-market purchases and 0 sales. Insiders bought $9.7 million and sold $0 worth of stock, for net insider buying of $9.7 million. The most recent filing shows Glavine Paul (Chief Growth Officer) reporting a transaction in 248,000 shares on Sep 30, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HELP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

HELP insider transactions

Helus Pharma insider transactions
DateInsiderTypeSharesValueFiling
Sep 30, 2026So Eric H. L.DirectorAward248,000—Form 4
Sep 30, 2026Glavine PaulChief Growth OfficerAward248,000—Form 4
Sep 29, 2026Cavers GregChief Financial OfficerBuy3,000$38.73KForm 4
Sep 21, 2026Halstead MichaelChief Executive OfficerBuy100,000$1.35MForm 4
Sep 8, 2026So Eric H. L.Executive ChairBuy100,000$1.24MForm 4
Sep 8, 2026Glavine PaulChief Growth OfficerBuy100,000$1.25MForm 4
Sep 8, 2026Glavine PaulChief Growth OfficerBuy100,000$1.25MForm 4
Sep 4, 2026So Eric H. L.Executive ChairBuy100,000$1.21MForm 4
Sep 3, 2026Glavine PaulChief Growth OfficerBuy100,000$1.18MForm 4
Sep 1, 2026So Eric H. L.Executive ChairBuy95,000$1.12MForm 4
Aug 31, 2026Glavine PaulChief Growth OfficerBuy90,000$1.04MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related